Insider · CIK 0001163556

FINE N SCOTT

Reports to the SEC for 6 companies · ABU DHABI

sec.gov

Transactions

Companies

Filings

CIK

0001163556

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-03	Cyclo Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+266K sh	—	—	266,354
2023-10-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockX Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	−299K sh	$0.13	−$37.4K	0
2023-10-20	Cyclo Therapeutics, Inc.X Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	+299K sh	$0.71	+$213K	743,804
2023-10-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+329K sh	—	—	329,342
2023-04-20	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+299K sh	$0.71	+$213K	444,402
2023-04-20	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+299K sh	$0.13	+$37.4K	299,402
2023-03-07	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+98.7K sh	—	—	98,706
2022-02-28	Cyclo Therapeutics, Inc.Stock Options (Right to buy)A Award	Director, Chief Executive Officer	AAward	+74.9K sh	—	—	74,907
2022-02-07	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10.3K sh	$3.58	+$37K	145,000
2022-01-19	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$3.89	+$19.5K	134,666
2021-12-15	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$3.89	+$19.5K	129,666
2021-12-02	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$4.93	+$24.7K	124,666
2021-11-19	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$5.25	+$26.3K	119,666
2021-09-15	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$6.35	+$31.8K	114,666
2021-08-27	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+57.3K sh	—	—	57,300
2021-01-13	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+10K sh	—	—	109,666
2020-12-11	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	—	—	20,000
2020-12-11	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	—	—	99,666
2020-08-27	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+500K sh	—	—	7,966,513
2020-08-27	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+500K sh	—	—	500,000
2020-04-24	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+730K sh	$0.10	+$73K	7,466,513
2019-09-18	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$0.17	+$1,750	6,736,483
2019-07-31	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+50K sh	$0.25	+$12.5K	6,726,483
2019-05-31	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+400K sh	—	—	400,000
2019-05-31	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+400K sh	—	—	6,676,483
2018-12-21	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+231K sh	—	—	230,769
2018-12-21	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+231K sh	—	—	6,276,483
2018-05-23	Cyclo Therapeutics, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+800K sh	—	—	6,045,714
2018-05-23	Cyclo Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−2,000 sh	—	—	0
2018-04-23	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+400K sh	—	—	400,000
2018-04-23	Cyclo Therapeutics, Inc.Series B Convertible Preferred StockP Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	—	—	2,000
2018-02-01	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	5,245,714
2017-10-18	Cyclo Therapeutics, Inc.Series B Convertible Preferred StockP Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	—	—	1,000
2017-10-18	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+400K sh	—	—	400,000
2017-06-30	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	5,225,714
2017-06-10	FWDIForward Industries, Inc.A Award	Director	AAward	+35K sh	—	—	105,000
2017-03-31	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	5,205,714
2017-02-23	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+286K sh	—	—	5,185,714
2017-02-23	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+286K sh	—	—	285,714
2016-07-22	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	4,900,000
2016-06-06	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+360K sh	—	—	4,880,000
2016-06-06	Cyclo Therapeutics, Inc.Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+360K sh	—	—	360,000
2016-02-23	FWDIForward Industries, Inc.A Award	Director	AAward	+35K sh	—	—	70,000
2015-02-23	FWDIForward Industries, Inc.A Award	Director	AAward	+35K sh	—	—	35,000
2014-11-07	Cyclo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+20K sh	—	—	4,520,000
2014-02-19	Cyclo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4.5M sh	$0.05	+$225K	4,500,000
2011-05-19	CENTRAL EUROPEAN DISTRIBUTION CORPStock Option (Right to Buy)A Award	Director	AAward	+8,250 sh	—	—	8,250
2011-05-19	CENTRAL EUROPEAN DISTRIBUTION CORPA Award	Director	AAward	+1,083 sh	—	—	3,707
2010-05-11	CENTRAL EUROPEAN DISTRIBUTION CORPS Sale	Director	SSale	−7,200 sh	$29.50	−$212K	2,624
2010-05-11	CENTRAL EUROPEAN DISTRIBUTION CORPS Sale	Director	SSale	−300 sh	$29.55	−$8,865	9,824

Recent filings

Accepted (ET)
Jun 54
FINE N SCOTT0001437749-24-019343
SEC(opens sec.gov)
Oct 234
FINE N SCOTT0001437749-23-028700
SEC(opens sec.gov)
Apr 244
FINE N SCOTT0001437749-23-010877
SEC(opens sec.gov)
Mar 94
FINE N SCOTT0001437749-23-006007
SEC(opens sec.gov)
Mar 24
FINE N SCOTT0001437749-22-005023
SEC(opens sec.gov)
Feb 74
FINE N SCOTT0001437749-22-002613
SEC(opens sec.gov)
Jan 194
FINE N SCOTT0001437749-22-001188
SEC(opens sec.gov)
Dec 154
FINE N SCOTT0001437749-21-028622
SEC(opens sec.gov)
Dec 24
FINE N SCOTT0001437749-21-027709
SEC(opens sec.gov)
Nov 194
FINE N SCOTT0001437749-21-027140
SEC(opens sec.gov)
Sep 154
FINE N SCOTT0001437749-21-022183
SEC(opens sec.gov)
Aug 304
FINE N SCOTT0001437749-21-021207
SEC(opens sec.gov)
Jan 254
FINE N SCOTT0001437749-21-001216
SEC(opens sec.gov)
Dec 144
FINE N SCOTT0001437749-20-025282
SEC(opens sec.gov)
Aug 284
FINE N SCOTT0001437749-20-018939
SEC(opens sec.gov)

Companies

Address

16TH FLOOR, AL-KHATEM TOWER WEWORK HUB71

ABU DHABI